Latest 20-F annual reports
NASDAQ
IPHA
Innate Pharma SAInnate Pharma grants Takeda exclusive worldwide rights to develop antibody drug conjugates (ADCs) for celiac disease, receiving an upfront payment and potential milestones totaling $415 million.
NASDAQ
Pharming Group N.V. files its 20-F, detailing amended articles of association and financial reporting for the year ended December 31, 2023.
NYSE
AEG
Aegon LTDAegon's latest Form 20-F filing provides a comprehensive overview of the company's financial performance, strategic initiatives, and risk management practices.
NASDAQ
20-F: CollPlant Biotechnologies Reports FY2023 Results, Highlights Progress in Regenerative Medicine
CollPlant Biotechnologies reports FY2023 results, highlighting a $10 million milestone payment from AbbVie and advancements in 3D-bioprinted breast implants.
NYSE
20-F: Navios Maritime Partners L.P. Navigates 2023 with Strategic Fleet Management and Financial Reporting
Navios Maritime Partners L.P. files its 20-F report, detailing fleet management, financial performance, and compliance with regulatory standards for the year ended December 31, 2023.
NASDAQ
ECARX and Xingji Meizu are partnering to develop and commercialize the Flyme Auto intelligent cockpit solution, leveraging their respective strengths in automotive technology and intelligent terminal design.
NASDAQ
Seanergy Maritime Holdings Corp. amends its 2011 Equity Incentive Plan and formalizes a policy for recovering erroneously awarded incentive compensation from key executives.
NASDAQ
20-F: IceCure Medical Establishes 2024 Employee Equity Incentive Plan and Files Annual Report on Form 20-F
IceCure Medical introduces a new employee equity incentive plan and files its annual report, highlighting its focus on cryoablation systems and technologies.
NASDAQ
IVA
Inventiva SAInventiva's recent 20-F filing details the company's securities, governance structure, and shareholder rights, providing a comprehensive overview for investors.
NYSE
ASE Technology Holding's 20-F filing provides a comprehensive overview of the company's financial performance, strategic initiatives, and risk factors for the fiscal year ended December 31, 2023.
NASDAQ
20-F: A2Z Smart Technologies Corp. Reports Financial Results for Fiscal Year Ended December 31, 2023
A2Z Smart Technologies Corp. reports increased revenue driven by smart cart sales, but also significant operating losses and concerns about its ability to continue as a going concern.
20-F: BYND Cannasoft Enterprises Inc. Reports Financial Results for Fiscal Year Ended December 31, 2023
BYND Cannasoft Enterprises Inc. reported a net loss of $18.5 million for the fiscal year ended December 31, 2023, amid strategic shifts in its cannabis and CRM operations.
OTC.Pink
VEVMQ
Vicinity Motor CORPVicinity Motor Corp. reports its fiscal year 2023 results, highlighting revenue of $19.05 million amidst ongoing supply chain disruptions and strategic shifts towards electric vehicles.
NASDAQ
United Maritime Corporation's 20-F filing outlines the structure of its capital stock, including common and preferred shares, and details shareholder rights, purchase rights, and anti-takeover provisions.
NASDAQ
Check Point Software Technologies Ltd. releases its 20-F filing, detailing its financial performance and strategic initiatives for the fiscal year ended December 31, 2023.
OTC.Pink
FECOF
Fec Resources INCFEC Resources Inc. reports a net loss of $191,795 for the year ended December 31, 2023, and expresses concerns about its ability to continue as a going concern without additional financing.
NASDAQ
MicroCloud Hologram Inc.'s 20-F filing details the company's share structure, financial performance for the year ended December 31, 2023, and key aspects of its corporate governance.
NASDAQ
RDCM
Radcom LTDRADCOM announces a 12% increase in revenue for fiscal year 2023, reaching $51.6 million, and reports a net income of $3.7 million, a significant turnaround from previous years.
NASDAQ
Himax Technologies provides a detailed description of its securities, shareholder rights, and corporate governance practices as of December 31, 2023, in its latest 20-F filing.
NASDAQ
FSD Pharma and Celly Nutrition Corp. enter into an arrangement agreement for a reorganization transaction.
OTC.Pink
Tianan Technology Group Ltd. reports a shift in business model towards graphene-based health therapy amidst financial challenges and expresses substantial doubt about its ability to continue as a going concern.
NASDAQ
Genenta Science S.p.A. filed an amendment to its annual report on Form 20-F for the fiscal year ended December 31, 2023, to include the consent of its independent registered public accounting firm, Dannible & McKee, LLP.
NASDAQ
Cardiol Therapeutics secures an exclusive worldwide license from Meros Polymers for their cannabinoid delivery technology, aiming to develop novel therapies for cardiovascular and cardiopulmonary diseases.
NASDAQ
SPRC
Scisparc LTDSciSparc Ltd. reports a net loss of $5.9 million for 2023, alongside progress in cannabinoid therapy development and e-commerce operations.
NYSE
Telkom Indonesia completes the spin-off of its IndiHome business segment into Telkomsel to drive competitiveness and customer value through Fixed Mobile Convergence (FMC).
Jeffs Brands' 20-F filing reveals details of consulting agreements, financial performance, and risk factors as the company expands its e-commerce operations.
NASDAQ
B.O.S. Better Online Solutions reports a net profit increase to $2.01 million in 2023, driven by growth in the Supply Chain Solutions division.
Aspen Insurance Holdings amends its credit agreement and files its annual report on Form 20-F, detailing financial performance and key business strategies.
NYSE
Lifezone Metals Limited files its 20-F, highlighting advancements in the Kabanga Nickel Project and strategic partnerships, while reporting a significant net loss for the year.
NASDAQ
Shengfeng Development Limited files its annual report on Form 20-F, detailing corporate structure, key agreements, and financial performance, while also extending a key road freight transportation cooperation agreement.